Bacterial skin infections
Conditions
Interventions
Sponsors
Debre Berhan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Healthy volunteers without skin diseases or any other diseases (acute or chronic) from both sexes • Available for follow-up observations during the clinical trial period • Willing to avoid using topical or systemic steroids or antihistamines for at least 7 days prior to trial initiation and during the duration of the trial
Exclusion criteria
Exclusion criteria: • A history of adverse reactions to adhesive tape • Participants with hypersensitive skin; skin abnormalities, such as severe acne, erythema, or telangiectasia at the test site • Participants who use the same or similar cosmetics (or pharmaceuticals) on the test site within three months • Those who have undergone a skin peeling or having wrinkles removed within six months of the interview
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety of the herbal ointments | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Incidence and severity of treatment emergent adverse events 2. Incidence and magnitude of treatment emergent laboratory abnormalities 3. Changes from baseline on skin irritation assessment scores after treatment. | — |
Countries
Ethiopia
Contacts
Public ContactMelat Gebremedhin Teklewolde
Armauer Hansen Research Institute
Outcome results
None listed